Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of the New Technologies to Detect précocément a Respiratory Exacerbation at Patients Reached by Cystic Fibrosis.

NCT02122289 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02122289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02122289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of the New Technologies to Detect précocément a Respiratory Exacerbation at Patients Reached by Cystic Fibrosis.
Lead sponsor
University Hospital, Montpellier
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
January 31, 2016
Enrollment
45 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis